Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
نویسندگان
چکیده
The crude incidence of lung cancer in the European Union in 2002 was 55.5/100 000/year, mortality rate being 50.6/100 000/ year. Rates among men were 87.7 and 80.1/100 000/year, and among women 24.8 and 22.4/100 000/year, respectively (GLOBOCAN 2002, http://www-dep.iarc.fr). Small-cell lung cancer (SCLC) accounts for 15–18% of all cases. In recent years the incidence of SCLC has decreased. SCLC is strongly associated with tobacco smoking.
منابع مشابه
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M. Sørensen, M. Pijls-Johannesma & E. Felip On behalf of the ESMO Guidelines Working Group* Department of Oncology, The Finsen Centre, Copenhagen, Denmark; Department of Radiation Oncology, MAASTRO Clinic, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands; Me...
متن کاملAdvanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up B. Glimelius & J. Oliveira On behalf of the ESMO Guidelines Working Group* Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala and Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden; Service of Medical Oncology, Portuguese Institute of Oncology, Lisb...
متن کامل2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers,...
متن کاملInvasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up J. Bellmunt, S. Albiol & V. Kataja On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology, University Hospital del Mar; Department of Medical Oncology, Instituto Oncológico Teknon, Barcelona, Spain; Department of Oncology, Vaasa Central Hospital, Vaasa and Kuopio University Hosp...
متن کاملSoft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up P. G. Casali, L. Jost, S. Sleijfer, J. Verweij & J.-Y. Blay On behalf of the ESMO Guidelines Working Group* Department of Cancer Medicine, Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology, Kantonsspital, Bruderholz, Switzerland; Department of Medical Oncology, Erasmus University Medical...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 18 Suppl 2 شماره
صفحات -
تاریخ انتشار 2007